The extensive research provided down below leads me to believe that ArrayIT Corp (ticker symbol: ARYC) is undervalued and loading at these levels could be worth wild.
SEC form 15 was submitted and approved.
"Option C is especially attractive to a Company that is in excess of two years delinquent in its reporting requirements and cannot reasonably obtain the records necessary to complete its audits for those years beyond the two-year period."
The term investors briefing would make it seem that the participation of seminars and investor events are going to start taking place as global lab expansion and possible joint ventures are explored.
Studies performed in Saudi Arabia and from pilot programs are now being provided. The studies shown are remarkable (please review them as they are referenced & dated on the link below).
"Optimum Allergy Solutions’ Test and Treat Program for Allergies and Asthma” at the request of the DIAD health authority from Dubai, UAE, and the Ministry of Health, Saudi Arabia.”
By viewing the below links it would be understood that PAS/OAS is a marketing company that spawned out from VantageRx due to the growing demand from the allergy fingerstick test coupled with the Allerdent immunotherapy treatment option.
VantageRx has a nationwide network of over 1,800 independent representatives to educate healthcare practices on unique ancillary products and services. The flagship program is Optimum Allergy Solutions - a revolutionary allergy test & treatment program where providers test & treat for allergies in their office (a fingerstick blood test for 180 allergens and treat with prescribed toothpaste.)
They nailed a huge VA contract that became effective this month (February 2020). This is mentioned as a direct contract, which avoids the hassle of dealing with insurance companies (refer to the investors briefing video up top). The video link further depicts a potential revenue chart, which would show the company possibly being able to bill around $1 million per day by summer 2020.
Twin Arbor Analytical utilizes cutting edge technologies such as Arrayit’s (ARYC) proprietary microarray platform. This system was developed as a research cooperative agreement with the United States Department of Agriculture – Agricultural Research Services (USDA-ARS) as a low-cost high throughput system for the analysis of microbial contaminants such as E. coli, salmonella, listeria, Noro virus and Hepatitis A.